ADVERTISEMENT
Videos
Efficacy, Safety of Ribociclib Plus Letrozole for ER+/HER2- Breast Cancer
11/28/2020
Mattea Reinisch, MD, highlights the final efficacy and safety results of the phase 3b, multi-center, open label Ribecca trial for women with ER+, HER2- locally advanced or metastatic breast cancer, presented as a poster at the virtual SABCS meeting.
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Visit the OLN Excellence Forums
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement